Luxturna – “Now Approved” Websites Dec 26, 2017Dec 24, 2017 Brand: Luxturna (voretigene neparvovec-rzyl), Injection Parent Company: Spark Therapeutics Drug Type: Prescription Drug Category: Ophthalmology Campaign: now-approved Targeting: HCPs, Patients, Caregivers Patient Website: https://luxturna.com/ HCP Website: https://luxturnahcp.com/ Patients’ Homepage Patients’ About Page Patients’ First Step Page Patients’ Screener Patients’ Mobile Homepage HCP Homepage HCP About Page HCP Identify Patients Page HCP Order Test Kits Page